Although plasma p‐tau181 and p‐tau231 appear to be useful markers of ADNC in DLB, with good concordance with CSF and PET measures, universal cutoffs have not yet been established for the p‐tau assays used in this study due to substantial inter‐ and intra‐laboratory variation.52 This evidence concerns the gene MAPT and Lewy body dementia.